The Hepatic Encephalopathy Therapeutics Market is expected to grow, at a CAGR of 6% during the forecast period 2022-2028. Hepatic encephalopathy (HE) is the leading cause of death in patients suffering from acute liver failure and in patients with cirrhosis and associated end-stage liver disease. People with hepatic encephalopathy lose the ability to metabolize ammonia, […]
Tag Archives: Hepatic Encephalopathy Therapeutics Market
The Hepatic Encephalopathy Therapeutics Market is poised to grow at a CAGR of 6% during the forecast period 2022-2028. Hepatic encephalopathy (HE) is the leading cause of death in patients suffering from acute liver failure and in patients with cirrhosis and associated end-stage liver disease. People with hepatic encephalopathy lose the ability to metabolize ammonia, […]